Tildrakizumab Found Effective, Safe in Elderly Patients With Psoriasis
Written by
American Journal Managed Care
Published
0
comments
0
min
A multicenter study finds no difference in outcomes between frail and nonfrail elderly patients treated with tildrakizumab over 2 years.